Enveric Biosciences (ENVB) EBT (QoQ) (2010 - 2026)
Enveric Biosciences (ENVB) EBT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Enveric Biosciences | 5.50 Mn | -2.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.34% |
| Dec 31, 2025 | 52.71% |
| Sep 30, 2025 | 25.62% |
| Jun 30, 2025 | -15.30% |
| Mar 31, 2025 | 30.58% |
| Dec 31, 2024 | -51.03% |
| Sep 30, 2024 | -10.89% |
| Jun 30, 2024 | 23.45% |
| Mar 31, 2024 | -167.37% |
| Dec 31, 2023 | 229.42% |
| Sep 30, 2023 | 55.70% |
| Jun 30, 2023 | -35.88% |
| Mar 31, 2023 | -60.59% |
| Dec 31, 2022 | -17.50% |
| Sep 30, 2022 | 47.34% |
| Jun 30, 2022 | 1.93% |
| Mar 31, 2022 | 90.59% |
| Dec 31, 2021 | -1,100.38% |
| Sep 30, 2021 | -23.27% |
| Jun 30, 2021 | 53.45% |